000 | 01041 a2200277 4500 | ||
---|---|---|---|
005 | 20250511175206.0 | ||
264 | 0 | _c19930401 | |
008 | 199304s 0 0 eng d | ||
022 | _a0284-186X | ||
024 | 7 |
_a10.3109/02841869209089719 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOstenstad, B | |
245 | 0 | 0 |
_aDisodium pamidronate versus mithramycin in the management of tumour-associated hypercalcemia. _h[electronic resource] |
260 |
_bActa oncologica (Stockholm, Sweden) _c1992 |
||
300 |
_a861-4 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypercalcemia _xblood |
650 | 0 | 4 |
_aNeoplasms _xcomplications |
650 | 0 | 4 | _aPamidronate |
650 | 0 | 4 |
_aPlicamycin _xtherapeutic use |
700 | 1 | _aAndersen, O K | |
773 | 0 |
_tActa oncologica (Stockholm, Sweden) _gvol. 31 _gno. 8 _gp. 861-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/02841869209089719 _zAvailable from publisher's website |
999 |
_c1297163 _d1297163 |